HALO AP

Indica Labs, HALO AP Dx, FDA 510(k)-cleared digital pathology platform displayed with the Aperio GT 450 DX Scanner for in vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems

ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.

Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems Read More »

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution

Discover how Guardant Health has seamlessly integrated Lunit SCOPE PD-L1 with HALO AP® for enhanced PD-L1 analysis.

An Automated Clinical Workflow Integrating an AI-driven PD-L1 22C3 Scoring Algorithm into a Browser-Based Digital Pathology Solution Read More »

Indica Labs’ Bay Area HALO® User Group Meeting 2025

21 October 2025 | Indica Labs is pleased to announce our Bay Area HALO® User Group Meeting at The Lighthouse Café & Conference Center on 21 October from 10:00am – 3:30pm. Lunch will be provided to all pre-registered attendees at 12:20pm.

Indica Labs’ Bay Area HALO® User Group Meeting 2025 Read More »

Scroll to Top